van Schaik, Ivo N ;
Mielke, Orell ;
Bril, Vera...
van Schaik , I N , Mielke , O , Bril , V , van Geloven , N , Hartung , H-P , Lewis , R A , Sobue , G , Lawo , J-P , Praus , M , Durn , B L , Cornblath , D R , Merkies , I S J , Sabet , A , George , K , Roberts , L , Carne , R , Blum , S , Henderson , R , Van Damme , P , Demeestere , J , Larue , S , D'Amour , C , Bril , V , Breiner , A , Kunc , P , Michal , M , Sussova , J , Tomas , K , Talab , R , Michal , B , Toomsoo , T , Rubanovits , Gross-Paju , K , Sorro , U , Saarela , M , Auranen , M , Pouget , J , Attarian , S , Le Masson , G , Wielanek-Bachelet , A , Desnuelle , C , Delmont , E , Clavelou , P , Aufauvre , D , Schmidt , J , Mori , M , Visser , N , Faber , C , Hoeijmakers , J & PATH Study Grp 2019 , ' Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP : PATH extension study ' , Neurology: Neuroimmunology & Neuroinflammation , vol. 6 , no. 5 , 590 . https://doi.org/10.1212/NXI.0000000000000590.
,
2019
